Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease

RETRACTED: IDF23-0574 Role of urinary HO, 8-iso-PGF2α, and serum oxLDL/β2GP1 complex in the diabetic kidney disease.

Diabetes research and clinical practice·2025

RUNX1, but not its familial platelet disorder mutants, synergistically activates PF4 gene expression in combination with ETS family proteins.

Journal of thrombosis and haemostasis : JTH·2013

Aspirin insensitive thromboxane generation is associated with oxidative stress in type 2 diabetes mellitus.

Thrombosis research·2012

[Post-infectious clinical-immunological syndrome and its place in clinical practice].

Terapevticheskii arkhiv·2010

Pathophysiology of beta2-glycoprotein I in antiphospholipid syndrome.

Lupus·2010

High-density lipoprotein inversely relates to its specific autoantibody favoring oxidation in thrombotic primary antiphospholipid syndrome.

Lupus·2010

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Lancet (London, England)·2026

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

Lancet (London, England)·2026

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Lancet (London, England)·2026

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Lancet (London, England)·2026

Evaluation of Thyroid Gland Vascularity in Hashimoto's Thyroiditis Using Ultra-Microangiography Vascular Imaging Technique.

Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine·2026

Cutaneous ultrastructure reveals potential biomarkers of ventricular arrhythmias in inflammatory cardiomyopathy.

Ultrastructural pathology·2026

Hippo signaling and vestigial-like family member 3 at the stromal-immune interface in autoimmunity.

Trends in molecular medicine·2026

Inflammatory rhabdomyoblastic tumor: Clinicopathologic and genomic features, association with neurofibromatosis type 1, and progression to rhabdomyosarcoma.

Pathology, research and practice·2026

Low dose methotrexate enhances lymphocytic JAM-A expression in rheumatoid arthritis.

International immunopharmacology·2026

Perioperative adrenal insufficiency presenting as refractory hypotension: A CARE-compliant article.

Medicine·2026

Related Experiment Videos

Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease

Related Concept Videos

RETRACTED: IDF23-0574 Role of urinary HO, 8-iso-PGF2α, and serum oxLDL/β2GP1 complex in the diabetic kidney disease.

RUNX1, but not its familial platelet disorder mutants, synergistically activates PF4 gene expression in combination with ETS family proteins.

Aspirin insensitive thromboxane generation is associated with oxidative stress in type 2 diabetes mellitus.

[Post-infectious clinical-immunological syndrome and its place in clinical practice].

Pathophysiology of beta2-glycoprotein I in antiphospholipid syndrome.

High-density lipoprotein inversely relates to its specific autoantibody favoring oxidation in thrombotic primary antiphospholipid syndrome.

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Evaluation of Thyroid Gland Vascularity in Hashimoto's Thyroiditis Using Ultra-Microangiography Vascular Imaging Technique.

Cutaneous ultrastructure reveals potential biomarkers of ventricular arrhythmias in inflammatory cardiomyopathy.

Hippo signaling and vestigial-like family member 3 at the stromal-immune interface in autoimmunity.

Inflammatory rhabdomyoblastic tumor: Clinicopathologic and genomic features, association with neurofibromatosis type 1, and progression to rhabdomyosarcoma.

Low dose methotrexate enhances lymphocytic JAM-A expression in rheumatoid arthritis.

Perioperative adrenal insufficiency presenting as refractory hypotension: A CARE-compliant article.

Related Experiment Videos

Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease

Related Concept Videos

Related Articles